Tocqueville Asset Management L.P. A Tyr Pharma Inc Transaction History

Tocqueville Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $9,500 - $15,080	-2,000 Reduced 16.46%	10,150 $54,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $19,683 - $25,650	-2,700 Reduced 18.18%	12,150 $91,000
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $62,666 - $185,328	14,850 New	14,850 $135,000
Q1 2021 May 17, 2021	SELL	$3.53 - $8.06 $76,601 - $174,902	-21,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.07 - $4.66 $66,619 - $101,122	21,700 New	21,700 $84,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.